Ted R Mikuls Selected Research

Rheumatoid Arthritis

11/2022	Elevations in adipocytokines and mortality in rheumatoid arthritis.
10/2022	Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis.
9/2022	Peptidyl arginine deiminase expression and macrophage polarization following stimulation with citrullinated and malondialdehyde-acetaldehyde modified fibrinogen.
6/2022	Increased susceptibility to organic dust exposure-induced inflammatory lung disease with enhanced rheumatoid arthritis-associated autoantigen expression in HLA-DR4 transgenic mice.
3/2022	Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis.
1/2022	Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis.
1/2022	Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
1/2022	Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
1/2022	Adipocytokines and achievement of low disease activity in rheumatoid arthritis.
1/2022	Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ted R Mikuls Research Topics

Disease

132	Rheumatoid Arthritis 11/2022 - 01/2002
23	Gout 05/2022 - 03/2004
23	Arthritis (Polyarthritis) 01/2022 - 01/2002
19	Inflammation (Inflammations) 11/2022 - 12/2009
9	Infections 12/2017 - 01/2009
8	Osteoarthritis 01/2021 - 06/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 05/2005
6	Disease Progression 01/2022 - 01/2003
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2004
6	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 04/2013
6	Periodontitis 12/2017 - 02/2010
5	Neoplasms (Cancer) 11/2022 - 10/2016
5	Lung Diseases (Lung Disease) 06/2022 - 01/2019
5	Hyperuricemia 03/2022 - 03/2006
5	COVID-19 12/2021 - 01/2021
5	Pain (Aches) 01/2021 - 02/2010
5	Myocardial Infarction 12/2015 - 01/2013
4	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 01/2021
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2009
4	Hypertension (High Blood Pressure) 06/2018 - 12/2003
3	Osteoporosis 11/2022 - 05/2005
3	Experimental Arthritis 06/2022 - 01/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2013
3	Obesity 10/2021 - 12/2017
3	Joint Diseases (Joint Disease) 02/2021 - 12/2009
3	Necrosis 05/2019 - 01/2003
3	Heart Failure 01/2019 - 01/2003
3	Stroke (Strokes) 02/2016 - 01/2013
3	Weight Loss (Weight Reduction) 01/2016 - 11/2005
2	Chronic Renal Insufficiency 03/2022 - 12/2014
2	Tuberculosis (Tuberculoses) 01/2022 - 01/2003
2	Genetic Risk Score 01/2022 - 01/2016
2	Insulin Resistance 01/2022 - 05/2005
2	Morbid Obesity 10/2021 - 05/2019

Drug/Important Bio-Agent (IBA)

32	Methotrexate (Mexate)FDA LinkGeneric 10/2022 - 01/2003
27	AutoantibodiesIBA 11/2022 - 01/2009
17	Uric Acid (Urate)IBA 05/2022 - 03/2004
17	Anti-Citrullinated Protein AntibodiesIBA 10/2021 - 02/2010
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
14	Biological ProductsIBA 05/2019 - 01/2002
13	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2012
12	Prednisone (Sone)FDA LinkGeneric 11/2022 - 08/2005
12	AntibodiesIBA 01/2022 - 10/2008
12	Antirheumatic Agents (DMARD)IBA 12/2021 - 01/2011
11	CytokinesIBA 11/2022 - 06/2013
11	Allopurinol (Remid)FDA LinkGeneric 03/2022 - 02/2009
10	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2003
9	Malondialdehyde (Propanedial)IBA 01/2022 - 01/2014
9	AcetaldehydeIBA 01/2022 - 01/2014
9	Rheumatoid FactorIBA 01/2022 - 09/2006
9	Etanercept (Enbrel)FDA Link 11/2021 - 12/2012
9	cyclic citrullinated peptideIBA 01/2021 - 09/2006
8	EpitopesIBA 01/2022 - 02/2008
8	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 12/2012
8	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2019 - 01/2009
7	Pharmaceutical PreparationsIBA 05/2022 - 01/2003
6	AutoantigensIBA 06/2022 - 10/2008
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 08/2003
6	Immunoglobulin A (IgA)IBA 01/2022 - 09/2013
6	ChemokinesIBA 08/2021 - 06/2013
6	acetyl 4-aminosalicylic acidIBA 01/2020 - 08/2013
6	Immunoglobulin G (IgG)IBA 12/2019 - 09/2013
5	Vitamin D FDA LinkGeneric 01/2022 - 01/2004
5	AntigensIBA 01/2022 - 04/2013
5	Immunoglobulin M (IgM)IBA 10/2021 - 04/2014
5	GlucocorticoidsIBA 01/2021 - 01/2014
5	Peptides (Polypeptides)IBA 12/2019 - 10/2008
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 02/2008
5	EnzymesIBA 12/2017 - 03/2012
4	Extracellular Matrix ProteinsIBA 09/2022 - 10/2016
4	LipidsIBA 01/2022 - 06/2014
4	Infliximab (Remicade)FDA Link 11/2021 - 01/2003
4	VaccinesIBA 11/2021 - 01/2021
4	Doxycycline (Periostat)FDA LinkGeneric 01/2020 - 02/2006
3	AdipokinesIBA 11/2022 - 01/2022
3	Adalimumab (Humira)FDA Link 11/2021 - 01/2016
3	Air Pollutants (Pollutants, Air)IBA 11/2021 - 10/2011
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 12/2003
3	Colchicine FDA LinkGeneric 01/2021 - 02/2009
3	AntioxidantsIBA 01/2020 - 02/2003
3	ProdrugsIBA 01/2018 - 01/2010
3	ImmunosorbentsIBA 12/2017 - 04/2013
3	C-Reactive ProteinIBA 12/2017 - 08/2005
2	LeptinIBA 11/2022 - 03/2022
2	AdiponectinIBA 11/2022 - 03/2022
2	Fibrinogen (Factor I)FDA Link 09/2022 - 12/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2022 - 10/2017
2	tofacitinibIBA 01/2022 - 01/2018
2	Interleukin-33IBA 11/2021 - 11/2021
2	golimumab FDA Link 11/2021 - 02/2018
2	LipopolysaccharidesIBA 11/2021 - 01/2010
2	salicylhydroxamic acid (SHAM)IBA 11/2021 - 01/2019
2	Hazardous Substances (Hazardous Materials)IBA 11/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 10/2021 - 01/2021

Therapy/Procedure

33	Therapeutics 10/2022 - 03/2004
6	Biological Therapy 02/2021 - 10/2014
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2015 - 01/2013
3	Percutaneous Coronary Intervention 03/2016 - 01/2013
3	Arthroplasty 01/2013 - 03/2010
2	Drug Therapy (Chemotherapy) 11/2021 - 11/2005